Jinjun Shi, Associate Professor

Jinjun Shi, Associate Professor

Harvard University

H-index: 69

North America-United States

About Jinjun Shi, Associate Professor

Jinjun Shi, Associate Professor, With an exceptional h-index of 69 and a recent h-index of 55 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Nanomedicine, Biomaterials, RNA therapy, Immunotherapy, Antioxidative Therapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis

Targeting Epsins to Inhibit FGF Signaling while Potentiating TGF-β Signaling Constrains Endothelial-to-Mesenchymal-Transition in Atherosclerosis

Stimuli‐Responsive Nanotechnology for RNA Delivery

Epsin nanotherapy regulates cholesterol transport to fortify atheroma regression

Bioengineered nanotechnology for nucleic acid delivery

Hydrogels for RNA delivery

Nano-targeting Epsin In Cholesterol Uptake-efflux Fortifies Atheroma Regression

‘Passive’nanoparticles for organ-selective systemic delivery: design, mechanism and perspective

Jinjun Shi, Associate Professor Information

University

Position

Brigham and Women's Hospital, Harvard Medical School

Citations(all)

21342

Citations(since 2020)

14253

Cited By

12914

hIndex(all)

69

hIndex(since 2020)

55

i10Index(all)

102

i10Index(since 2020)

96

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Jinjun Shi, Associate Professor Skills & Research Interests

Nanomedicine

Biomaterials

RNA therapy

Immunotherapy

Antioxidative Therapy

Top articles of Jinjun Shi, Associate Professor

Title

Journal

Author(s)

Publication Date

Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis

Bandana Singh

Kui Cui

Shahram Eisa-Beygi

Bo Zhu

Douglas B Cowan

...

2024/3/26

Targeting Epsins to Inhibit FGF Signaling while Potentiating TGF-β Signaling Constrains Endothelial-to-Mesenchymal-Transition in Atherosclerosis

bioRxiv

Yunzhou Dong

Beibei Wang

Mulong Du

Bo Zhu

Kui Cui

...

2022/1/1

Stimuli‐Responsive Nanotechnology for RNA Delivery

Hui Zhou

Dean Shuailin Chen

Caleb J Hu

Xuechuan Hong

Jinjun Shi

...

2023/12

Epsin nanotherapy regulates cholesterol transport to fortify atheroma regression

Circulation research

Kui Cui

Xinlei Gao

Beibei Wang

Hao Wu

Kulandaisamy Arulsamy

...

2023/1/6

Bioengineered nanotechnology for nucleic acid delivery

Yang Zhang

Jing Luo

Xiran Gui

Yating Zheng

Eric Schaar

...

2023/12/1

Hydrogels for RNA delivery

Ruibo Zhong

Sepehr Talebian

Bárbara B Mendes

Gordon Wallace

Robert Langer

...

2023/3/20

Nano-targeting Epsin In Cholesterol Uptake-efflux Fortifies Atheroma Regression

Arteriosclerosis, Thrombosis, and Vascular Biology

Kui Cui

Xinlei Gao

Beibei Wang

Hao Wu

Yunzhou Dong

...

2023/5

‘Passive’nanoparticles for organ-selective systemic delivery: design, mechanism and perspective

Liyi Fu

Yang Zhang

Ryan A Farokhzad

Bárbara B Mendes

João Conde

...

2023

ROS-Responsive Nanoparticle Delivery of mRNA and Photosensitizer for Combinatorial Cancer Therapy

Nano Letters

Hui Zhou

Yuqin Liao

Xiangfei Han

Dean Shuailin Chen

Xuechuan Hong

...

2023/4/24

Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles

Nature biomedical engineering

Sejin Son

Jutaek Nam

April S Kim

Jinsung Ahn

Kyung Soo Park

...

2023/1

Targeting epsins to inhibit fibroblast growth factor signaling while potentiating transforming growth factor-β signaling constrains endothelial-to-mesenchymal transition in …

Circulation

Yunzhou Dong

Beibei Wang

Mulong Du

Bo Zhu

Kui Cui

...

2023/2/21

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

Nature Reviews Cardiology

Wei Chen

Maaike Schilperoort

Yihai Cao

Jinjun Shi

Ira Tabas

...

2022/3/21

Targeting Epsins by nanotherapy regulates lipid metabolism and promotes ABCG1-mediated cholesterol efflux to fortify atheroma regression

bioRxiv

Kui Cui

Xinlei Gao

Beibei Wang

Hao Wu

Yunzhou Dong

...

2022/8/9

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Nature communications

Yuling Xiao

Jiang Chen

Hui Zhou

Xiaodong Zeng

Zhiping Ruan

...

2022/2/9

Stimuli-responsive nanoparticles for biomedical applications

2022/7/21

Methods for treating cancer

2024/2/27

Targeting Macrophage Epsins Inhibits Lipid Uptake And Facilitates Cholesterol Efflux In Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Kui Cui

Xinlei Gao

Beibei Wang

Hao Wu

Yunzhou Dong

...

2022/5

Nanodelivery of nucleic acids

Bárbara B Mendes

João Conniot

Aviram Avital

Dongbao Yao

Xingya Jiang

...

2022/4/14

Restoration of tumor suppression using MRNA-based delivery system

2022/10/18

Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity

Cardiovascular Research

Roberto Molinaro

Mikyung Yu

Grasiele Sausen

Colette A Bichsel

Claudia Corbo

...

2021/11/15

See List of Professors in Jinjun Shi, Associate Professor University(Harvard University)

Co-Authors

H-index: 319
Robert Langer

Robert Langer

Massachusetts Institute of Technology

H-index: 148
Leaf Huang

Leaf Huang

University of North Carolina at Chapel Hill

H-index: 144
Daniel G. Anderson

Daniel G. Anderson

Massachusetts Institute of Technology

H-index: 132
Ulrich H. von Andrian

Ulrich H. von Andrian

Harvard University

H-index: 126
Omid Farokhzad

Omid Farokhzad

Harvard University

H-index: 105
Zhen Gu

Zhen Gu

University of California, Los Angeles

academic-engine